Pilot fMRI Studies of Aging-Related Effects of THC

Recruiting Phase 2 Interventional Study
THC
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Basic Science
Participants needed
10 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to begin investigating acute impairment of various forms of memory and learning by Tetrahydrocannabinol (THC) in cannabis (CNB) compared to placebo, in a 2-session per subject double-blind, random assignment, placebo-controlled counterbalanced design in young to middle-aged adults.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * CNB use within past 2 years and felt "high" when used. * Able to read, speak, and understand English. * Able and willing to provide written informed consent, and willing to commit to the study protocol. Exclusion Criteria: * Current marijuana tolerance, desire to cut down, o…
Contacts

Godfrey Pearlson, MD

860-305-8921

godfrey.pearlson@yale.edu

CONTACT

Ariana Caruso

ariana.caruso2@hhchealth.org

CONTACT